Chapter 12. Software Design Ethics for Biomedicine

  1. Sylvia Nagl
  1. Don Gotterbarn1 and
  2. Simon Rogerson2

Published Online: 16 MAY 2006

DOI: 10.1002/0470032898.ch12

Cancer Bioinformatics: From Therapy Design to Treatment

Cancer Bioinformatics: From Therapy Design to Treatment

How to Cite

Gotterbarn, D. and Rogerson, S. (2006) Software Design Ethics for Biomedicine, in Cancer Bioinformatics: From Therapy Design to Treatment (ed S. Nagl), John Wiley & Sons, Ltd, Chichester, UK. doi: 10.1002/0470032898.ch12

Editor Information

  1. Department of Oncology, Royal Free and University College Medical School, Rowland Hill Street, London NW3 2PF, UK

Author Information

  1. 1

    Computer and Information Science Department, East Tennessee State University, Box 70711, Johnson City, TN 37614-1266, USA

  2. 2

    Centre for Computing and Social Responsibility, De Montford University, The Gateway, Leicester LE1 9BH, UK

Publication History

  1. Published Online: 16 MAY 2006
  2. Published Print: 27 JAN 2006

ISBN Information

Print ISBN: 9780470863046

Online ISBN: 9780470032893



  • biomedicine software design ethics;
  • software failures;
  • Software Development Impact Statement (SoDIS);
  • ‘cancer cluster identification’ program;
  • SoDIS Project Auditor (SPA);
  • Project type identification (stage 1A);
  • Stakeholder role identification (stage 1B);
  • ethical concern screen;
  • medical software development


This chapter contains sections titled:

  • The problem: software and research

  • Risk identification

  • Biomedical software example

  • Is an ethical risk analysis required?

  • Details of SoDIS

  • A SoDIS analysis of the biomedical software example

  • Conclusion